IONETIX AND ATONCO SIGN A PARTNERSHIP AGREEMENT TO FIGHT BLADDER CANCER
Michimich.com/10175862

Trending...
LANSING, Mich., May 18, 2022 /PRNewswire/ -- The companies Atonco (Nantes-Saint Herblain, France) and IONETIX Corporation (Lansing, MI) have signed a partnership agreement to ensure the radioisotope production and supply of the radiopharmaceutical necessary for the success of Atonco's clinical studies and commercialization in the United States.

More on Michimich.com
Atonco, a radiopharmaceutical company at the clinical stage, aims to demonstrate through its clinical research program the relevance of a breakthrough therapeutic treatment, alpha immunotherapy, targeting superficial bladder cancer.
Filed Under: Business

Show All News | Report Violation

0 Comments

Latest on Michimich.com